Content
02/13/2024
Seattle, WA USA
ProfoundBio
completed $112 million Series B Round funding. Investors include
Surveyor Capital, RA Capital Management, Piper Heartland Healthcare Capital, OrbiMed Advisors, Nextech Invest, Medicxi, LYFE Capital, Logos Capital, Lilly Asia Ventures, LifeSci Venture Partners, Janus Henderson Investors, Ally Bridge Group.
About
ProfoundBio is now part of Genmab. As part of Genmab, we are looking forward to continuing our work of developing novel antibody-based therapeutics for patients with cancer. This page will no longer be active or monitored. For updates on our work, please follow Genmab at: https://bit.ly/3Kf80df.
Startup
Sector:
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
